Early assessment of the efficacy of temozolomide chemotherapy in experimental glioblastoma using [18F]FLT-PET imaging.
<h4>Unlabelled</h4>Addition of temozolomide (TMZ) to radiation therapy is the standard treatment for patients with glioblastoma (GBM). However, there is uncertainty regarding the effectiveness of TMZ. Considering the rapid evolution of the disease, methods to assess TMZ efficacy early du...
Main Authors: | Thomas Viel, Sonja Schelhaas, Stefan Wagner, Lydia Wachsmuth, Katrin Schwegmann, Michael Kuhlmann, Cornelius Faber, Klaus Kopka, Michael Schäfers, Andreas H Jacobs |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23861829/pdf/?tool=EBI |
Similar Items
-
Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma
by: Norbert Galldiks, et al.
Published: (2010-01-01) -
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma
by: Sharareh Gholamin, et al.
Published: (2020-02-01) -
Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
by: Hannah Strobel, et al.
Published: (2019-09-01) -
Considering the Experimental use of Temozolomide in Glioblastoma Research
by: Verena J. Herbener, et al.
Published: (2020-06-01) -
Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
by: Pingde Zhang, et al.
Published: (2018-01-01)